logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Bevacizumab/capecitabine/cyclophosphamideThrombocytopenia: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2019年 / 1751卷 / 1期
关键词:
D O I:
10.1007/s40278-019-61203-9
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:70 / 70
相关论文
共 50 条
  • [1] CyclophosphamideThrombocytopenia: case report
    Reactions Weekly, 2021, 1884 (1) : 150 - 150
  • [2] CyclophosphamideThrombocytopenia: case report
    Reactions Weekly, 2011, 1380 (1) : 15 - 15
  • [3] Bevacizumab/capecitabine/irinotecanNausea: case report
    Reactions Weekly, 2017, 1650 (1) : 61 - 61
  • [4] Bevacizumab/capecitabine/irinotecanNeutropenia: case report
    Reactions Weekly, 2019, 1761 (1) : 85 - 85
  • [5] CyclophosphamideThrombocytopenia: case report
    Reactions Weekly, 2015, 1533 (1) : 144 - 144
  • [6] CyclophosphamideThrombocytopenia: case report
    Reactions Weekly, 2013, 1453 (1) : 17 - 17
  • [7] Bevacizumab/capecitabine/oxaliplatinLack of efficacy: case report
    Reactions Weekly, 2024, 2025 (1) : 88 - 88
  • [8] Bevacizumab/capecitabine/docetaxelVarious toxicities: case report
    Reactions Weekly, 2014, 1491 (1) : 12 - 12
  • [9] Bevacizumab/capecitabine/oxaliplatinLack of efficacy: case report
    Reactions Weekly, 2023, 1975 (1) : 85 - 85
  • [10] Bevacizumab/capecitabine/oxaliplatinGastrointestinal perforation: case report
    Reactions Weekly, 2020, 1796 (1) : 58 - 58
← 12345 →